Evolution of personalized dosimetry for radioembolization of hepatocellular carcinoma
Abstract Yttrium-90 transarterial radioembolization (TARE) has progressed from a salvage or
palliative lobar or sequential bilobar regional liver therapy for patients with advanced …
palliative lobar or sequential bilobar regional liver therapy for patients with advanced …
Clinical, dosimetric, and reporting considerations for Y-90 glass microspheres in hepatocellular carcinoma: updated 2022 recommendations from an international …
R Salem, SA Padia, M Lam, C Chiesa, P Haste… - European Journal of …, 2023 - Springer
Purpose In light of recently published clinical reports and trials, the TheraSphere Global
Dosimetry Steering Committee (DSC) reconvened to review new data and to update …
Dosimetry Steering Committee (DSC) reconvened to review new data and to update …
Friend or foe? Locoregional therapies and immunotherapies in the current hepatocellular treatment landscape
S Young, J Hannallah, D Goldberg, T Sanghvi… - International Journal of …, 2023 - mdpi.com
Over the last several decades, a number of new treatment options for patients with
hepatocellular carcinoma (HCC) have been developed. While treatment decisions for some …
hepatocellular carcinoma (HCC) have been developed. While treatment decisions for some …
A global evaluation of advanced dosimetry in transarterial radioembolization of hepatocellular carcinoma with Yttrium-90: the TARGET study
M Lam, E Garin, M Maccauro, SC Kappadath… - European Journal of …, 2022 - Springer
Purpose To investigate the relationships between tumor absorbed dose (TAD) or normal
tissue absorbed dose (NTAD) and clinical outcomes in hepatocellular carcinoma (HCC) …
tissue absorbed dose (NTAD) and clinical outcomes in hepatocellular carcinoma (HCC) …
Hepatocellular carcinoma radiation segmentectomy treatment intensification prior to liver transplantation increases rates of complete pathologic necrosis: an explant …
SA Montazeri, C De la Garza-Ramos, AR Lewis… - European Journal of …, 2022 - Springer
Purpose To verify the correlation between yttrium-90 glass microsphere radiation
segmentectomy treatment intensification of hepatocellular carcinoma (HCC) and complete …
segmentectomy treatment intensification of hepatocellular carcinoma (HCC) and complete …
Yttrium-90 radiation segmentectomy of hepatocellular carcinoma: a comparative study of the effectiveness, safety, and dosimetry of glass-based versus resin-based …
A Villalobos, L Arndt, B Cheng, H Dabbous… - Journal of Vascular and …, 2023 - Elsevier
Purpose To evaluate the differences in safety, effectiveness, and dosimetry between glass-
based and resin-based ablative yttrium-90 (90 Y) transarterial radioembolization (TARE) of …
based and resin-based ablative yttrium-90 (90 Y) transarterial radioembolization (TARE) of …
Voxel-based tumor dose correlates to complete pathologic necrosis after transarterial radioembolization for hepatocellular carcinoma
KT Pianka, M Barahman, J Minocha… - European Journal of …, 2024 - Springer
Purpose The transarterial radioembolization (TARE) dose is traditionally calculated using
the single-compartment Medical Internal Radiation Dose (MIRD) formula. This study utilized …
the single-compartment Medical Internal Radiation Dose (MIRD) formula. This study utilized …
Factors associated with complete pathologic necrosis of hepatocellular carcinoma on explant evaluation after locoregional therapy: a national analysis using the …
Please see the Editorial Comment by Hyeon Yu, discussing this article. To listen to the
podcast associated with this article, please select one of the following: iTunes, Google Play …
podcast associated with this article, please select one of the following: iTunes, Google Play …
Radiation segmentectomy for the treatment of solitary hepatocellular carcinoma: outcomes compared with those of surgical resection
C De la Garza-Ramos, SA Montazeri… - Journal of Vascular and …, 2022 - Elsevier
Purpose To investigate the outcomes of radiation segmentectomy (RS) versus standard-of-
care surgical resection (SR). Materials and Methods A multisite, retrospective analysis of …
care surgical resection (SR). Materials and Methods A multisite, retrospective analysis of …
[HTML][HTML] Image-guided percutaneous locoregional therapies for hepatocellular carcinoma
O Chevallier, K Zhao, B Marinelli… - Chinese Clinical …, 2023 - cco.amegroups.org
Hepatocellular carcinoma (HCC) is the most common primary liver cancer and the 3 rd
leading cause of cancer death worldwide. Treatment options include surgical resection, liver …
leading cause of cancer death worldwide. Treatment options include surgical resection, liver …